Year |
Citation |
Score |
2018 |
Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, Bowlby R, Matthew T, Danilova L, Hegde AM, Kim J, ... ... Sethi G, et al. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell. 33: 244-258.e10. PMID 29438696 DOI: 10.1016/J.Ccell.2018.01.003 |
0.348 |
|
2015 |
Pathak HB, Zhou Y, Sethi G, Hirst J, Schilder RJ, Golemis EA, Godwin AK. A Synthetic Lethality Screen Using a Focused siRNA Library to Identify Sensitizers to Dasatinib Therapy for the Treatment of Epithelial Ovarian Cancer. Plos One. 10: e0144126. PMID 26637171 DOI: 10.1371/Journal.Pone.0144126 |
0.52 |
|
2014 |
Sethi G, Kwon Y, Burkhalter RJ, Pathak HB, Madan R, McHugh S, Atay S, Murthy S, Tawfik OW, Godwin AK. PTN signaling: Components and mechanistic insights in human ovarian cancer. Molecular Carcinogenesis. PMID 25418856 DOI: 10.1002/Mc.22249 |
0.538 |
|
2014 |
Sharma P, Stecklein SR, Kimler BF, Sethi G, Petroff BK, Phillips TA, Tawfik OW, Godwin AK, Jensen RA. The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer. Journal of Cancer Therapeutics & Research. 3: 1-11. PMID 25177489 DOI: 10.7243/2049-7962-3-2 |
0.418 |
|
2014 |
Atay S, Banskota S, Crow J, Sethi G, Rink L, Godwin AK. Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proceedings of the National Academy of Sciences of the United States of America. 111: 711-6. PMID 24379393 DOI: 10.1073/Pnas.1310501111 |
0.476 |
|
2013 |
Pessetto ZY, Weir SJ, Sethi G, Broward MA, Godwin AK. Drug repurposing for gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 12: 1299-309. PMID 23657945 DOI: 10.1158/1535-7163.Mct-12-0968 |
0.478 |
|
2013 |
Sethi G, Pathak H, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, Gunewardena S, Birrer MJ, Godwin AK. Abstract A06: Integration of synthetic lethality and genomic data to identify significant molecular vulnerabilities in ovarian cancer Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Pms-A06 |
0.44 |
|
2012 |
Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson MB, Vathipadiekal V, Gunewardena S, Birrer MJ, Godwin AK. An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer. Plos One. 7: e47086. PMID 23056589 DOI: 10.1371/Journal.Pone.0047086 |
0.54 |
|
2012 |
Somasundaram RT, Ramalingam S, Subramaniam D, Sethi G, Weir J, Nirmalanandhan VS, Godwin AK, Shrikant A, Sittampalam GS. Abstract 433: Expression of stem cell and EMT markers on circulating tumor cells Cancer Research. 72: 433-433. DOI: 10.1158/1538-7445.Am2012-433 |
0.407 |
|
2011 |
Sethi G, Pathak HB, Zhang H, Zhou Y, Einarson M, Godwin AK. Abstract 4969: RNA interference screens to identify genes essential for ovarian tumor growth and maintenance Cellular and Molecular Biology. 71: 4969-4969. DOI: 10.1158/1538-7445.Am2011-4969 |
0.335 |
|
2010 |
Caldwell SA, Jackson SR, Shahriari KS, Lynch TP, Sethi G, Walker S, Vosseller K, Reginato MJ. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene. 29: 2831-42. PMID 20190804 DOI: 10.1038/Onc.2010.41 |
0.353 |
|
Show low-probability matches. |